KATHERINE KOWALK: Open Payments
NPI 1790382240 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 35 payments from 16 companies in 2025. Trend: 2023 $780 · 2024 $1,217 · 2025 $848
Food & beverage: $780Education: $68
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $134 |
| PFIZER INC. | 4 | $98 |
| Janssen Biotech, Inc. | 2 | $91 |
| Merck Sharp & Dohme LLC | 3 | $87 |
| Antares Pharma, Inc. | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 1 | $35 |
| Teleflex LLC | 1 | $31 |
| ABBVIE INC. | 2 | $30 |
| Boston Scientific Corporation | 1 | $28 |
Products named: XTANDI, GEMTESA, Nubeqa, ERLEADA, KEYTRUDA, XYOSTED, ADSTILADRIN, BARRIGEL.
Industry payments across CO — which companies pay providers there.
